Be a part in building the category leader for a very large franchise, based on our novel and unique platform.
Brain disorders represent a very large market opportunity
- 4 billion humans (half of the world’s population) is suffering from brain disorders
- Annual loss of 500 million healthy life years
- > $2 trillion of economical impact
The brain-nose interface opens a window to the brain
- Non-invasive, easy and frequent access
- Very large number of brain-specific biomarkers (> 4,500 proteins reliably detected in nasal secretion)
- Little signal disruption through anatomical proximity
Novel and unique method to detect, measure and validate brain-specific biomarkers
- Proprietary collection and sample preparation
- Comprehensive multi-modal analytical workbench
- Unique AI-supported data analytics
Strong value proposition combining new biomarker platform with data driven medicine
- Large sets of curated clinical data
- Patient stratification and treatment personalization
- Replication oncology approach
Applicability to a broad range of indication and disease areas
- Neurodegenerative diseases (Alzheimer, Parkinson etc.)
- Neurological disorders (Migraine, Schizophrenia)
- Tumors, inflammatory diseases and more…